Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma

BACKGROUND: To explore the pyruvate kinase M2 (PKM2) expression profile as a prognostic marker of lung adenocarcinoma (LUAD) as well as lung squamous cell carcinoma (LUSC). METHODS: Retrospective bioinformatics analysis of data from the Cancer Genome Atlas-Lung Cancer dataset and the Human Protein A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junxia, Zhang, Chengjuan, Liu, Xianghua, Sun, Ning, Zhang, Caili, Li, Ruiqin, Zhang, Zhenqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798821/
https://www.ncbi.nlm.nih.gov/pubmed/35117696
http://dx.doi.org/10.21037/tcr.2020.04.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798821/
https://www.ncbi.nlm.nih.gov/pubmed/35117696
http://dx.doi.org/10.21037/tcr.2020.04.23

Ejemplares similares